Current practice in the use of antiplatelet agents in the peri-operative period by UK vascular surgeons

Annals of the Royal College of Surgeons of England

Volumn 85, Issue 2, 2003, Pages 97-101

  Smout, Jonathan ^a   Stansby, Gerard ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Antiplatelet; Peri operative; Questionnaire; Vascular surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN;

ANEURYSM SURGERY; AORTA ANEURYSM; ARTICLE; BLEEDING; BLOOD CLOTTING; BYPASS SURGERY; CAROTID ENDARTERECTOMY; DRUG HYPERSENSITIVITY; DRUG USE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; INGUINAL REGION; LONG TERM CARE; MEDICAL PRACTICE; MEDICAL SOCIETY; PERIOPERATIVE PERIOD; QUESTIONNAIRE; SURGEON; THROMBOSIS; UNITED KINGDOM; VARICOSIS; VASCULAR DISEASE; VASCULAR SURGERY; VEIN SURGERY;

AORTIC ANEURYSM, ABDOMINAL; ASPIRIN; CONSENSUS; GASTROINTESTINAL DISEASES; GREAT BRITAIN; HUMANS; INTRAOPERATIVE CARE; IRELAND; PLATELET AGGREGATION INHIBITORS; PROFESSIONAL PRACTICE; QUESTIONNAIRES; VASCULAR SURGICAL PROCEDURES;

EID: 0037344278     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588403321219858     Document Type: Article

References (18)

1. Anon. Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
2. Johnston KW. Nonruptured abdominal aortic aneurysm: Six-year follow-up results from the multicenter prospective Canadian aneurysm study. Canadian Society for Vascular Surgery Aneurysm Study Group. J Vasc Surg 1994; 20: 163-70.
3. Bayly PJ, Matthews JN, Dobson PM, Price ML, Thomas DG. In-hospital mortality from abdominal aortic surgery in Great Britain and Ireland: Vascular Anaesthesia Society audit. Br J Surg 2001; 88: 687-92.
4. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001; 88: 787-800.
5. Jackson M, Clagett P. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 2001; 119 (Supp 1): 283S-99S.
6. McCollum C, Alexander C, Kenchington G, Franks PJ, Greenhalgh RM. Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial. J Vasc Surg 1991; 13: 150-61.
7. Dacey LJ, Munoz JJ, Johnson ER, Leavitt BJ, Maloney CT, Morton JR et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000; 70: 1986-90.
8. Swarup V, Oh CJ, Richard EN, Fischman DL, Savage MP. Risk of post-operative hemorrhage associated with ticlopidine or clopidogrel use prior to coronary artery bypass grafting. Circulation 2000; 102 (Suppl 2): II-648.
9. Hongo R, Ley J, Yee R. Impact of preoperative clopidogrel in coronary artery bypass grafting. Circulation 2000; 102 (Suppl 2): II-555.
10. Yende S, Wunderink R. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29: 2271-5.
11. Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561-8.
12. Thompson JF, Mullee MA, Bell PR, Campbell WB, Chant AD, Darke SG et al. Intraoperative heparinisation, blood loss and myocardial infarction during aortic aneurysm surgery: A Joint Vascular Research Group Study. Eur J Vasc Endovasc Surg 1996; 12: 86-90.
13. Powell JT, Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM. Are we ignoring the importance of ankle pressures in patients with abdominal aortic aneurysm? Eur J Vasc Endovasc Surg 2001; 21: 65-9.
14. Sanmuganathan PS, Ghahramani P, Jackson PR, Wallis EJ, Rarnsay LE. Aspirin for primary prevention of coronary heart disease: Safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2001; 85: 265-71.
15. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
16. Weinstein WM. Proton pump inhibitors and H. pylori infection: Why the concern? Curr Gastroenterol Report 1999; 1: 507-10.
17. Pohle T, Domschke W. Results of short- and long-term medical treatment of gastroesophageal reflux disease (GERD). Langenbecks Arch Surg 2000; 385: 317-23.
18. The Clopidogrel in Unstable angina to prevent Recurrent Events investigators C. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.